September 2005
Your Search Results
-
Promoted Content
-
Promoted Content
January 2021Alzheimer Disease Sourcebook, 8th Ed.
by James Chambers, General Editor
Provides consumer health information about symptoms, diagnosis, and treatment of Alzheimer disease and other dementias, along with tips for coping with memory loss and related complications and advice for caregivers. Includes index, glossary of related terms, directory of resources.
-
Trusted Partner
June 2016Eat to Beat Alzheimer's
by Francie Healey
Eat to Beat Alzheimer's offers a practical guide and an empowering tool to bring nourishing, healthful, and delicious food into the lives of people concerned about Alzheimer's and other cognitive problems. Almost 9 million people in the U.S. suffer from Alzheimer's and other forms of dementia, and the toll is rapidly increasing. This book will appeal to everyone concerned about dementia and memory loss in either themselves or a loved one.Recent research makes clear that the impact of aging on the brain can be reduced by simple diet and lifestyle modifications. The delicious food choices and easy-to-prepare recipes in this book are based on the latest findings showing that they can help slow the progression of Alzheimer's and other conditions like it, or prevent them entirely.Readers will gain the knowledge and tools to take charge of their health by incorporating tasty, healing foods into their diet. The information in this cookbook will be as relevant and useful 20 years from now as it is today. And the recipes will still be just as delicious.
-
Trusted Partner
January 2019Alzheimer's Disease and Other Dementias, Second Edition
by Sonja M. Lillrank, M.D. and Dana K. Cassell; Foreword by Pat Levitt, Ph.D., Vice President, Chief Scientific Officer, and Director, The Saban Research Institute; Director, USC Neuroscience Graduate Program
Dementias are brain disorders that impair memory, thinking, behavior, and physical activity. Alzheimer's disease is the most common form, affecting 50 to 60 percent of dementia patients, and yet the exact cause of Alzheimer's and how best to detect it early remain unknown. Alzheimer's Disease and Other Dementias, Second Edition provides helpful clarification of this group of diseases and their specific types. It explains how to recognize the symptoms of dementia or Alzheimer's disease, how these disorders are diagnosed, the latest theories about their cause, and how they can be treated. Also covered are the outlook for future prevention and treatment and resources providing further information for those seeking help coping with dementia.
-
Trusted Partner
-
Trusted Partner
September 2011Vergiss Alzheimer!
Die Wahrheit über eine Krankheit, die keine ist
by Stolze, Cornelia
-
Trusted Partner
March 2004Gedächtnisstörungen, Demenz, Alzheimer
Vorbeugung, Diagnose, Behandlung Warnsignale erkennen, Risikofaktoren ausschalten Ein Ratgeber für Patienten und Angehörige
by Neumann, Bernd; Dr. med. Schäfer, Ulrich
-
Trusted Partner
-
Trusted Partner
August 2018
Alzheimer kann man vorbeugen
Was wir jetzt essen müssen, um unseren Kopf für später fit zu halten
by Cuneo, Cinzia / Übersetzt von Krabbe, Wiebke
-
Trusted Partner
October 2000Alzheimer Roulette. Die Frauenfalle
Stücke und Materialien
by Friedrich-Karl Praetorius
-
Trusted Partner
-
Trusted Partner
January 2021How to understand a new disease
Patrol report
by Wang Liming
This book sorts out major events in life sciences from November 2019 to October 2020. In the first part, the author focuses on the progress made by scientists, especially Chinese scientists, in the context of the new crown epidemic. Including how to discover the new coronavirus, treat new coronary pneumonia, vaccine research and other issues that readers are concerned about. In the second part, the author combed the progress in the field of life sciences in 2020, including cutting-edge scientific researches such as organ transplantation, Alzheimer's disease, and gene editing. This book is recommended by Han Qide and He Fan in a preface. It is suitable for party and government agencies, practitioners in the pharmaceutical industry, and readers who care about life sciences.
-
Trusted Partner
Biography & True StoriesNovember 2024Walking in the dark
James Baldwin, my father and I
by Douglas Field
A moving exploration of the life and work of the celebrated American writer, blending biography and memoir with literary criticism. Since James Baldwin's death in 1987, his writing - including The Fire Next Time, one of the manifestoes of the Civil Rights Movement, and Giovanni's Room, a pioneering work of gay fiction - has only grown in relevance. Douglas Field was introduced to Baldwin's essays and novels by his father, who witnessed the writer's debate with William F. Buckley at Cambridge University in 1965. In Walking in the dark, he embarks on a journey to unravel his life-long fascination and to understand why Baldwin continues to enthral us decades after his death. Tracing Baldwin's footsteps in France, the US and Switzerland, and digging into archives, Field paints an intimate portrait of the writer's life and influence. At the same time, he offers a poignant account of coming to terms with his father's Alzheimer's disease. Interweaving Baldwin's writings on family, illness, memory and place, Walking in the dark is an eloquent testament to the enduring power of great literature to illuminate our paths.
-
Medicine1987Alzheimer Disease & Associated Disorders
An International Journal
by Edited by Charles DeCarli MD
Quarterly - 2013 Volume(s) - 25 www.alzheimerjournal.com Alzheimer Disease and Associated Disorders is a leading international forum for reports of new research findings and new approaches to diagnosis and treatment. Contributions fall within all relevant scientific fields and clinical specialties, including neurobiology, neurochemistry, molecular biology, neurology, neuropathology, neuropsychology, psychiatry, gerontology, and geriatrics. Rigorous peer review of articles is ensured by an international Editorial Advisory Board of eminent scientists and clinicians.
-
Volver
by Valentina Iriarte
"En casa. En cualquier lugar. No hay nada más que lo cotidiano, lo mínimo, la rutina. Lo que sucede todos los días, sin embargo, es una forma de recordar". Este libro álbum retrata sutilmente el encuentro entre dos ancianos que se encuentran cada día en un asilo de ancianos, que trata el tema del Alzheimer y la experiencia que tiene la gente cuando empieza de cero todos los días. Este álbum, no lo publiques todavía. pero su ISBN está listo. formato A4 Libro Album que aún no ha sido impreso, trata del Alzheimer, esta dirigido a crear empatía a los cuidadores de las personas que padecen Demencia Senil.
-
Neurology & clinical neurophysiologyApril 2012Alzheimer's Diagnostic Guideline Validation
Exploration of Next Steps: Workshop Summary
by Diana E. Pankevich, Theresa Wizemann, and Bruce M. Altevogt, Rapporteurs; Forum on Neuroscience and Nervous Systems Disorders; Board on Health Sciences Policy; Institute of Medicine
Scientific advances during the last decade now indicate that Alzheimer's disease is a continuous, progressive cognitive disease, most likely beginning many years before dementia is apparent. To discuss the next steps in validating new diagnostic guidelines for Alzheimer's disease, the IOM Forum on Neuroscience and Nervous System Disorders hosted a public workshop session at the Alzheimer's Association International Conference.
-
Diseases & disordersJanuary 2011Future Opportunities to Leverage the Alzheimer's Disease Neuroimaging Initiative
Workshop Summary
by Theresa Wizemann, Diana E. Pankevich, and Bruce M. Altevogt, Rapporteurs; Forum on Neuroscience and Nervous System Disorders; Institute of Medicine
Nearly 5.3 million Americans are living with Alzheimer's disease, and 26.6 million people are affected worldwide. The Alzheimer's Disease Neuroimaging Initiative (ADNI), a public-private partnership, provides a publicly available, international database of clinical and imaging data to foster research and collaboration on Alzheimer's research worldwide. The Institute of Medicine held a workshop on July 12, 2010, to explore opportunities to use information from and partnerships formed because of ADNI to continue to improve the understanding and treatment of Alzheimer's disease.
-
Is it Alzheimer's?
101 Answers to Your Most Pressing Questions about Memory Loss and Dementia
by Peter Rabins, MD
Dr. Rabins is coauthor of The 36-Hour Day. He has long been active in the field of dementia and Alzheimer research and education. The book features his answers to the questions that audiences most often ask him about Alzheimer disease and dementia. The questions are organized into seven sections (progressing from basics about memory loss and aging to more complex topics about caregiving and ethical dilemmas).
-
Biography & True StoriesBird-Bent Grass
A Memoir, in Pieces
by Kathleen Venema
Bird-Bent Grass chronicles an extraordinary mother–daughter relationship that spans distance, time, and, eventually, debilitating illness. Personal, familial, and political narratives unfold through the letters that Geeske Venema-de Jong and her daughter Kathleen exchanged during the late 1980s and through their weekly conversations, which started after Geeske was diagnosed with Alzheimer’s disease twenty years later. In 1986, Kathleen accepted a three-year teaching assignment in Uganda, after a devastating civil war, and Geeske promised to be her daughter’s most faithful correspondent. The two women exchanged more than two hundred letters that reflected their lively interest in literature, theology, and politics, and explored ideas about identity, belonging, and home in the context of cross-cultural challenges. Two decades later, with Geeske increasingly beset by Alzheimer’s disease, Kathleen returned to the letters, where she rediscovered the evocative image of a tiny, bright meadow bird perched precariously on a blade of elephant grass. That image – of simultaneous tension, fragility, power, and resilience – sustained her over the years that she used the letters as memory prompts in a larger strategy to keep her intellectually gifted mother alive. Deftly woven of excerpts from their correspondence, conversations, journal entries, and email updates, Bird-Bent Grass is a complex and moving exploration of memory, illness, and immigration; friendship, conflict, resilience, and forgiveness; cross-cultural communication, the ethics of international development, and letter-writing as a technology of intimacy. Throughout, it reflects on the imperative and fleeting business of being alive and loving others while they’re ours to hold.
-
Diseases & disordersFebruary 2016Assessing the Impact of Applications of Digital Health Records on Alzheimer's Disease Research
Workshop Summary
by Lisa Bain and Sheena Posey Norris, Rapporteurs; Forum on Neuroscience and Nervous System Disorders; Board on Health Sciences Policy; Institute of Medicine; National Academies of Sciences, Engineering, and Medicine
Health information technology is providing patients, clinicians, and researchers with access to data that will enable novel approaches to science and medicine. Digital health records (DHRs) are capable of being shared across different health care settings for the examination of possible trends and long-term changes in a patient's disease progression or status as well as the effectiveness of the health care delivery system. While prevalence of paper records remains high, there has been a rapid trend toward the digitalization of medical and health records in many countries. DHRs are widely viewed as essential for improving health, reducing medical errors, and lowering costs. However, given that these databases have the potential to house the complete medical and health information of individuals, the potential misuse, de-identification or breaching of this data may have serious implications. On July 20, 2015, the Institute of Medicine's Forum on Neuroscience and Nervous System Disorders held a public session at the 2015 Alzheimer's Association International Conference to assess the impact of DHRs on Alzheimer's disease (AD) research. An estimated 46.8 million people worldwide are currently living with dementia, and the prevalence is expected to double every year for the next 20 years. Given the few therapies currently available to treat the symptoms of AD, compared to other central nervous system disorders, participants explored how DHRs may be used to help improve clinical trial design and methodology for AD research. This report summarizes the presentations and discussions from this workshop.
